Simultaneous isolation of emm89-type Streptococcus pyogenes strains with a wild-type or mutated covS gene from a single streptococcal toxic shock syndrome patient.
Streptococcal toxic shock syndrome (STSS) is a re-emerging infectious disease in many developed countries. Recent studies have suggested that mutations in CovRS, a two-component regulatory system in Streptococcus pyogenes, play important roles in the pathogenesis of STSS. However, in vivo evidence of the significance of CovRS in human infections has not been fully demonstrated. We investigated five S. pyogenes strains isolated simultaneously from the pharynx, sputum, knee joint, cerebrospinal fluid and blood of a single STSS patient. All were emm89-type strains, and multilocus sequence typing (MLST) analysis revealed that the strains of pharynx and blood were isogenic. The growth rates of the strains from pharynx and sputum were faster than those of the other strains. Protein profiles of the culture supernatants of strains from the pharynx and sputum were also different from those of the other strains. Sequence analyses revealed that strains from the knee joint, cerebrospinal fluid and blood contained a single nucleotide difference in the covS coding region, resulting in one amino acid change, compared with the other strains. Introduction of a plasmid containing the covS gene from the pharynx strain to the blood strain increased the production of SpeB protein. This suggests that the one amino acid alteration in CovS was relevant to pathogenesis. This report supports the idea that mutated CovS plays important roles in vivo in the dissemination of S. pyogenes from the upper respiratory tract of human to aseptic tissues such as blood and cerebrospinal fluid.
Nagoya City Public Health Research Institute, Nagoya, Japan.|Department of Bacteriology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
Katsuaki
K
Masuno
Department of Bacteriology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
Ryo
R
Okada
Department of Bacteriology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
Yan
Y
Zhang
Department of Bacteriology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
Masanori
M
Isaka
Department of Bacteriology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
Ichiro
I
Tatsuno
Nagoya City Public Health Research Institute, Nagoya, Japan.
Shinichiro
S
Shibata
Department of Bacteriology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
Tadao
T
Hasegawa
D000942:Antigens, Bacterial / Q000235:genetics*; D001425:Bacterial Outer Membrane Proteins / Q000235:genetics*; D001426:Bacterial Proteins / Q000096:biosynthesis; D002352:Carrier Proteins / Q000235:genetics*; D060085:Coinfection / Q000382:microbiology*; D004269:DNA, Bacterial / Q000235:genetics; D005098:Exotoxins / Q000096:biosynthesis; D000071677:Histidine Kinase; D006801:Humans; D047908:Intracellular Signaling Peptides and Proteins / Q000235:genetics*; D058885:Multilocus Sequence Typing; D050505:Mutant Proteins / Q000235:genetics; D020125:Mutation, Missense; D012772:Shock, Septic / Q000382:microbiology*; D013290:Streptococcal Infections / Q000382:microbiology*; D013297:Streptococcus pyogenes / Q000145:classification / Q000235:genetics* / Q000254:growth & development / Q000302:isolation & purification
D000942:Antigens, Bacterial; D001425:Bacterial Outer Membrane Proteins; D001426:Bacterial Proteins; D002352:Carrier Proteins; D004269:DNA, Bacterial; D005098:Exotoxins; D047908:Intracellular Signaling Peptides and Proteins; D050505:Mutant Proteins; C027951:erythrogenic toxin; C014689:streptococcal M protein; C534547:CovS protein, Streptococcus pyogenes; D000071677:Histidine Kinase